Zimmer Biomet Holdings, Inc. logo

Zimmer Biomet Holdings, Inc. Z1BH34

Market Closed
8 Nov, 19:55
B3 B3
R$
148. 08
0
0%
R$
25.09B Market Cap
24.97 P/E Ratio
0.96% Div Yield
0 Volume
8.06 Eps
R$ 148.08
Previous Close
Day Range
148.08 148.08
Year Range
146.4 172.2

Z1BH34 Chart

Zimmer Biomet Holdings, Inc. Profile

Medical Devices Industry
Healthcare Sector
Mr. Ivan Tornos CEO
B3 Exchange
US98956P1021 ISIN
US Country
18,000 Employees
30 Sep 2024 Last Dividend
1 Mar 2022 Last Split
25 Jul 2001 IPO Date
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Contact Information

Address: 345 East Main Street, Warsaw, IN, United States, 46580
Phone: 574 373 3333